Thyroid Cancer Trial, Recruiting NCT07059507 Sponsor: Minia University Condition: Thyroid Cancer
Back to Thyroid Cancer

Thyroid Cancer Trial, Recruiting

NCT07059507
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with Graves' disease, confirmed through symptoms (such as an enlarged thyroid or eye problems) and blood tests showing abnormal thyroid hormone levels and/or a positive antibody test
  • You have a medical reason to have your entire thyroid removed, such as: hyperthyroidism returning or not improving after taking antithyroid medications; having a bad reaction or intolerance to antithyroid medications; preferring surgery over other treatments; having a large thyroid causing discomfort or difficulty breathing/swallowing; having a suspicious thyroid nodule found before surgery; or having moderate to severe eye problems related to Graves' disease where radioactive iodine treatment is not recommended
  • You are already scheduled to have a complete (total) thyroidectomy — meaning full removal of the thyroid gland
  • You are willing and able to sign a consent form agreeing to take part
  • You are able to understand what the study involves and what will be required of you

Who may not be able to join:

  • You are under 18 years of age
  • You have had thyroid surgery in the past
  • You have previously had radiation treatment to your neck
  • You have been diagnosed with thyroid cancer before the surgery, confirmed by a biopsy (confirm with trial site)
  • You are not able to give informed consent, for example due to a cognitive or mental health condition
  • Your main reason for having thyroid surgery is something other than Graves' disease, such as a large non-cancerous multinodular goiter
  • You are having only part of your thyroid removed, rather than the whole gland

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Saleh K Saleh, MD, Minia University

Phone: 01201765401

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Minia University
Registry
ClinicalTrials.gov
Start date
15 July 2025
Est. completion
15 July 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Prevalence of Incidental Thyroid Carcinoma (ITC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov